Tandem therapy LutaPol/ItraPol (177Lu / 90Y-DOTATATE) as an effective method in the treatment of neuroendocrine neoplasms

Description of the study: The aim of the study is to develop an algorithm for the treatment of GEP-NET patients using ItraPol and LutaPol isotope mixtures (177Lu-DOTATATE and 90Y-DOTATATE) based on personalized dosimetry. The specific goal is to assess the effectiveness and safety of personalized treatment of GEP-NET patients using 177Lu-DOTATATE and 90Y-Lu-DOTATATE mixtures compared to standard treatment of NEN patients using 177Lu-DOTATATE

National Center for Nuclear Research, POLATOM Radioisotope Center

Protocol number:

EudraCT number:

Project Manager/Main Investigator:
dr Renata Mikołajczak

Duration of the study:
2020 - 2026